Health
Alnylam Faces Challenges at Key Cardiology Conference
By Editor • August 27, 2026 • 1 min read
Alnylam Pharmaceuticals faces a crucial moment at the ESC Congress as a competitor's drug fails to perform, impacting its ATTR-CM treatments.
Read more